🇺🇸 FDA
Patent

US 10376590

Sustained delivery formulations of risperidone compound

granted A61KA61K31/519A61K47/22

Quick answer

US patent 10376590 (Sustained delivery formulations of risperidone compound) held by Indivior UK Limited expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Indivior UK Limited
Grant date
Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61K, A61K31/519, A61K47/22, A61K47/32, A61K47/34